XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2022 $ 222,351 $ 5 $ 557,867 $ (334,230) $ (1,291)
Beginning Balance (in shares) at Dec. 31, 2022   45,089,537      
Exercise of common stock options (in shares)   16      
Issuance of common stock upon vesting of RSUs (in shares)   1,662      
Stock-based compensation expense 3,614   3,614    
Unrealized gain or loss on investments 792       792
Net loss (23,945)     (23,945)  
Ending Balance at Mar. 31, 2023 202,812 $ 5 561,481 (358,175) (499)
Ending Balance (in shares) at Mar. 31, 2023   45,091,215      
Beginning Balance at Dec. 31, 2023 $ 224,088 $ 6 658,751 (434,927) 258
Beginning Balance (in shares) at Dec. 31, 2023 54,865,553 54,865,553      
Issuance of common stock, net $ 124,832 $ 1 124,831    
Issuance of common stock, net (in shares)   12,500,000      
Exercise of common stock options (in shares) 51,540 51,540      
Exercise of common stock options $ 198   198    
Issuance of common stock upon vesting of RSUs (in shares)   3,245      
Stock-based compensation expense 4,958   4,958    
Unrealized gain or loss on investments (420)       (420)
Net loss (25,011)     (25,011)  
Ending Balance at Mar. 31, 2024 $ 328,645 $ 7 $ 788,738 $ (459,938) $ (162)
Ending Balance (in shares) at Mar. 31, 2024 67,420,338 67,420,338